Abstract

The coupling of muscarinic receptors to second messenger responses was investigated in primary cultures of neurons from the fetal mouse brain. Neurons were mainained in monolayer culture, in serum-free medium; immunocytochemical studies found these cultures to be nearly exclusively neuronal. In striatal cultures, [ 3H]N-methylscopolamine (NMS) bound specifically and with high affinity ( K d= 70 pM) to a homogenous population of receptors on intact neurons (320 fmol/mg cellular protein). Displacement of the binding of [ 3H]NMS by pirenzepine indicated the presence of heterogeneou sites (81% high affinity site, K h= 51nM, K 1= 1.5 μM); AF-DX 116 showed the oppisite selectivity (15% high affinity sites, K rmh= 56nM, K 1= 1.5μM). The dopamine agonist SKF-3893 (1 μM) enhanced the accumulation of cylic adenosine monosphosphate (AMP) in these cultures 2.5-fold; addition of carbachol reduced cyclic AMP levels by 30% (EC 50, 1.7 μM). In the presence of 1 mM lithium, carbachol stimulated the accumulation of inositol monophosphate 5-fold (EC 50, 61 μM). Both responses were antagonized by pirenzepine (apparent K 1 of 23 nM for the phosphoinositide response and 200 nM for the cyclic AMP response) and AF-DX 116 (apparent K i 540 nM and 160 nM, respectively). In binding studies on braiinstem cultures, AF-DX 116 indicated the presence of two sites approximately equal abundance ( K h = 170nM, K 1= 2.9 υM); data for pirenzepine were adequately fit by one-site model ( K d= 630 nM. The efficacy of oxotremorine (compared to oxotremorine-M) in stimulating the phosphoinositide response was equally low in striatal and cortical cultures (0.07), but significantly greater in brainstem cultures (0.26). These studies suggest that the striatal phosphoinositide and cyclic AMP responses were mediated by M 1 and M 2 receptors, respectively, while the brainstem phosphoinositide response was mediated by M 3 receptors.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.